Hi all, brand new here. My NP just prescribed semaglutide and I have a question about glp-1 for type 1 diabetes as.

Sorry if this has been asked before — I did try searching but the amount of information here is overwhelming (in a good way). I am on day 3 and everything is new to me.

Any guidance appreciated. You all seem really knowledgeable and I am glad I found this community.

To answer the question about GLP-1 for type 1 diabetes as adjunct any emerging data? — in my experience this comes down to a few key factors.

I have been dealing with this for several months now, and what I have found is that individual responses really do vary. That said, the general consensus on GLP-1 for type 1 diabetes as seems solid.

What specifically worked for me: tracking everything in a spreadsheet. I would suggest EndoResFellow try the same approach and reporting back.

Dr.SurgeonPGH said:

— in my experience this comes down to a few key factors

Completely agree with Dr.SurgeonPGH. I would add that GLP-1 for type 1 diabetes as also has implications for body composition that sometimes get overlooked in these discussions.

In my case, following a similar approach led to fewer side effects compared to what I was doing before.

Subscribing to this thread. GLP-1 for type 1 diabetes is exactly what I've been researching. 🙏

As a healthcare provider, I want to add some clinical context to this discussion on GLP-1 for type 1 diabetes as adjunct .

Building on what EndoResFellow said — the evidence base here is well-established. The key publications to reference are from the FLOW program[1].

Key clinical points:

1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
2. Side effect profile is predictable and usually manageable with standard protocols
3. Monitoring should include baseline labs and follow-up at 3-month intervals
4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.